Asahi Kasei Ventricular Device Obtains U.S. FDA Clinical Study Approval
This article was originally published in PharmAsia News
Executive Summary
Asahi Kasei and Nagano-based Sun Medical Technology Research received an unconditional clinical study approval from U.S. FDA to implant its Evaheart left ventricular assist system for clinical trials